Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ambtu Lifesciences is an Indian healthcare and pharmaceutical company focused on bringing innovative and differentiated products to the South Asian market. The company acts as a strategic bridge for global innovators, facilitating the licensing, import, and local customization of formulations, active ingredients, and delivery technologies. Ambtu Lifesciences' portfolio spans pharmaceuticals, probiotics, and nutritional supplements across diverse therapeutic areas, including gastroenterology, gynecology, orthopedics, and anemia. Notably, the company has developed and commercialized micronized encapsulated ferric pyrophosphate (MEFP) using Lipotech SA's platform technology to treat iron deficiency anemia. Through strategic partnerships and access to world-class manufacturing facilities, Ambtu Lifesciences supports product development, clinical data generation, and collaborative marketing to maximize product lifecycles.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ambtu Life Sciences.